AngioDynamics, Inc. (ANGO) vs OrthoPediatrics Corp. (KIDS)

A side-by-side comparison of AngioDynamics, Inc. and OrthoPediatrics Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANGO vs KIDS

growth of $100 · dividends reinvested · last 9y
ANGO -7.2% (-0.8%/yr)KIDS +19.1% (+2.0%/yr)KIDS compounded faster over this window
100200300400Start $1002019202120232025$93$119
ANGO KIDS

ANGO vs KIDS: by the numbers

  • •ANGO is the larger company ($602M vs $589M market cap).
  • •Both run net losses; ANGO's is the smaller (-11.48% vs -15.72% net margin).
  • •KIDS grew revenue faster over the past five years (23.14% vs 1.93% CAGR).

Metrics side by side

Valuation

MetricANGOKIDS
P/S ratio1.882.33
P/B ratio3.531.71
FCF yield0.08%N/A

Profitability

MetricANGOKIDS
Gross margin54.62%73.65%
Operating margin-12.47%-9.01%
Net margin-11.48%-15.72%
ROE-21.51%-11.56%
ROIC-20.75%-4.97%

Growth (annualized)

MetricANGOKIDS
Revenue CAGR (5Y)1.93%23.14%
FCF CAGR (5Y)-51.49%N/A
Total return CAGR (5Y)-10.80%-18.40%

Frequently asked

Which has grown faster, ANGO or KIDS?
Over the past five years, KIDS grew revenue faster — ANGO at a 1.93% CAGR versus KIDS at 23.14%.
How have ANGO and KIDS total returns compared?
Over the past 5 years, ANGO delivered -10.80% and KIDS delivered -18.40% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.